Ovarian Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cancer, including details on symptoms, causes, treatment, information.

Volume 3 (2006), Issue 6 (June)

1. Diagnosis and management of epithelial ovarian cancer.
   Obstet Gynecol, 107(6): 1399-410. [Abstract] [Full-text]
2. Adverse impact of a history of violence for women with breast, cervical, endometrial, or ovarian cancer.
   Obstet Gynecol, 107(6): 1330-6. [Abstract] [Full-text]
3. Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays.
   Am J Clin Pathol, 126(1): 101-9. [Abstract] [Full-text]
4. Intake of folate and related nutrients in relation to risk of epithelial ovarian cancer.
   Am J Epidemiol, 163(12): 1101-11. [Abstract] [Full-text]
5. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads.
   J Clin Endocrinol Metab, 91(6): 2404-13. [Abstract] [Full-text]
6. Outcome of in vitro fertilization/intracytoplasmic sperm injection after laparoscopic cystectomy for endometriomas.
   Fertil Steril, 85(6): 1730-5. [Abstract] [Full-text]
7. Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer.
   Int J Cancer, 119(4): 875-83. [Abstract] [Full-text]
8. 4-HPR modulates gene expression in ovarian cells.
   Int J Cancer, 119(5): 1005-13. [Abstract] [Full-text]
9. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
   Int J Cancer, 119(2): 414-22. [Abstract] [Full-text]
10. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.
    Cancer Genet Cytogenet, 168(1): 44-9. [Abstract] [Full-text]
11. Sustained response to bevacizumab in refractory well-differentiated ovarian neoplasms.
    Gynecol Oncol, 102(1): 5-7. [Abstract] [Full-text]
12. Ovarian nongestational choriocarcinoma mixed with various epithelial malignancies in association with endometriosis.
    Gynecol Oncol, 102(1): 111-7. [Abstract] [Full-text]
13. Juvenile granulosa cell tumor of the ovary associated with tuberous sclerosis.
    Gynecol Oncol, 102(1): 118-20. [Abstract] [Full-text]
14. The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma.
    Gynecol Oncol, 102(1): 15-21. [Abstract] [Full-text]
15. Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma.
    Gynecol Oncol, 102(1): 8-14. [Abstract] [Full-text]
16. Biomarker discovery for ovarian cancer using SELDI-TOF-MS.
    Gynecol Oncol, 102(1): 61-6. [Abstract] [Full-text]
17. Ultrasound characteristics of different types of adnexal malignancies.
    Gynecol Oncol, 102(1): 41-8. [Abstract] [Full-text]
18. Prospective evaluations of continuous weekly paclitaxel regimen in recurrent platinum-resistant epithelial ovarian cancer.
    Gynecol Oncol, 102(1): 49-53. [Abstract] [Full-text]
19. Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.
    Gynecol Oncol, 102(1): 32-40. [Abstract] [Full-text]
20. High expression of tissue inhibitor of metalloproteinase-2 in serous ovarian carcinomas and the role of this expression in ovarian tumorigenesis.
    Hum Pathol, 37(7): 906-13. [Abstract] [Full-text]
21. Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis.
    Hum Pathol, 37(7): 883-9. [Abstract] [Full-text]
22. A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
    Hum Mutat, 27(7): 654-66. [Abstract] [Full-text]

© 2004-2010 Ovarian Cancer Research Today. All Rights Reserved.